Supernus Pharmaceuticals (SUPN) Q1 2026 Earnings

24FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
0.34
0.56
0.78
1.01

Details

Expected EPS
0.34
Actual EPS
0.845522
Surprise EPS
0.51
Surprise Percent
+148.68%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.845522 per share for Q1 2026.

0 Comments

Share your thoughts